Citigroup
C
$128.51
-0.94%
Citigroup Inc. is a global financial-services company operating in over 160 countries, providing a comprehensive suite of services including cross-border banking for multinational corporates, investment banking, trading, and credit card services in the United States. It is a systemically important global bank, distinguished by its vast international network and diversified operations across five primary segments: Services, Markets, Banking, US Personal Banking, and Wealth Management. The current investor narrative is dominated by a successful turnaround story, with recent robust quarterly results driving the stock to new highs, as the market focuses on the bank's execution of its strategic simplification plan, margin expansion, and its ability to navigate a volatile geopolitical and interest rate environment.…
C
Citigroup
$128.51
Related headlines
Investment Opinion: Should I buy C Today?
Rating & Thesis: Hold. Citigroup is a compelling turnaround story with significant upside if execution succeeds, but after a 109% annual surge, the risk/reward is balanced, warranting a wait for a better entry point or clearer evidence of sustained revenue growth. This aligns with the need for patience despite unanimous bullish analyst sentiment. Supporting Evidence: The stock trades at a reasonable forward P/E of 10.69x based on projected EPS of $18.10, a 28% discount to its trailing P/E, implying expected growth. It is valued at book value (PB of 1.00), providing a fundamental floor. Profitability is solid with an 11.78% operating margin, and analyst EPS estimates are tightly clustered with a high of $18.69, suggesting consensus on the path forward. However, the massive price appreciation and expanded trailing P/E of 14.89x limit near-term upside. Risks & Conditions: The thesis would upgrade to Buy on a pullback toward the $110-$115 support zone (improving margin of safety) or upon confirmation of sustained revenue growth above 5% YoY. It would downgrade to Sell if quarterly EPS meaningfully disappoints against the $18.10 trajectory, if the PB ratio falls sustainably below 0.9, or if geopolitical events cause a severe risk-off environment. Currently, the stock appears fairly valued relative to its near-term prospects but carries an elevated price tag for the promised future earnings.
Sign up to view all
C 12-Month Price Forecast
The outlook is bifurcated between a promising long-term turnaround and a near-term valuation that leaves little room for error. The base case is most probable, expecting the company to grind higher on meeting solid, but not spectacular, earnings targets. The bull case requires flawless execution and a benign macro backdrop to justify further multiple expansion. The key development to watch is the convergence (or divergence) of actual quarterly EPS toward the lofty $18.10 consensus. A downgrade to a bearish stance would occur on consecutive earnings misses, while an upgrade to bullish would require sustained revenue acceleration alongside EPS delivery.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Citigroup's 12-month outlook, with a consensus price target around $167.06 and implied upside of +30.0% versus the current price.
Average Target
$167.06
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$103 - $167
Analyst target range
Analyst coverage for Citigroup is substantial, with the data indicating at least 6 major firms providing estimates. The institutional ratings show a unanimously bullish sentiment, with recent actions from firms like Oppenheimer, JP Morgan, Morgan Stanley, RBC Capital, and Barclays all maintaining 'Outperform' or 'Overweight' equivalents. This pattern indicates strong institutional conviction in the stock's trajectory following its strategic updates and earnings results. The analyst revenue estimates for the forward period average $111.45 billion, with a range from a low of $108.68 billion to a high of $114.25 billion. The EPS estimates average $18.10, ranging from $17.51 to $18.69. While a specific consensus price target is not provided in the data, the tight clustering of revenue and EPS estimates, coupled with the unanimous bullish ratings, suggests a high degree of analyst confidence and a relatively narrow expected target price range. The lack of 'Hold' or 'Sell' ratings in the recent institutional data further underscores the prevailing positive sentiment on the street.
Bulls vs Bears: C Investment Factors
The bull case for Citigroup, centered on a successful multi-year turnaround and significant expected earnings growth, currently holds stronger evidence, supported by powerful price momentum, unanimous analyst conviction, and a valuation anchored at book value. However, the bear case presents credible near-term risks, primarily centered on valuation after a massive re-rating and stagnant top-line growth. The single most important tension in the investment debate is whether the projected dramatic leap in EPS to $18.10 materializes as forecasted. If execution falters or macro conditions worsen, the current premium trailing P/E of 14.89x could contract sharply. Conversely, successful delivery would justify the forward multiple and potentially drive the stock higher.
Bullish
- Powerful Turnaround Momentum: The stock has surged 108.98% over the past year and 21.63% in the past month, significantly outperforming the S&P 500. This momentum is driven by robust quarterly results and strong institutional conviction, as evidenced by unanimous 'Outperform' or 'Overweight' ratings from major analysts.
- Significant Earnings Growth Expected: Analysts project forward EPS of $18.10, a dramatic increase from the latest quarterly diluted EPS of $1.19. This growth is reflected in a forward P/E of 10.69x, a meaningful discount to the trailing P/E of 14.89x, indicating the market is pricing in substantial future earnings expansion.
- Valuation at Tangible Book Value: The stock trades at a Price-to-Book (PB) ratio of 1.00, indicating it is priced precisely at its reported book value. For a major bank, this often represents a valuation floor and provides a margin of safety, with any premium for successful execution being potential upside.
- Strong Profitability & Margin Expansion: The company maintains solid profitability with a trailing twelve-month operating margin of 11.78% and a net margin of 8.48%. The Q4 2025 gross margin of 43.2% improved from 41.6% in Q4 2024, demonstrating progress in the strategic simplification plan.
Bearish
- Extended Valuation & Technical Overbought: The stock trades at $132.18, approximately 99% of its 52-week high of $133.57, following a 109% annual gain. Its trailing P/E of 14.89x represents a significant expansion from 8.21x at the end of Q1 2025, suggesting much of the positive narrative is already priced in, increasing near-term consolidation risk.
- Revenue Growth Remains Stagnant: Q4 2025 revenue of $40.86 billion represented a slight year-over-year decline of -0.11%. While sequential improvement is possible, the top-line trajectory has been mixed, raising questions about the bank's ability to achieve consistent organic growth amidst a complex operating environment.
- High Financial Leverage: The company operates with a debt-to-equity ratio of 3.37, which is typical for a major bank but represents significant financial leverage. This amplifies risks in a rising interest rate or economic downturn scenario, potentially pressuring net interest margins and capital ratios.
- Macro & Geopolitical Sensitivity: With a beta of 1.085, the stock is slightly more volatile than the market. Recent news highlights risks from geopolitical tensions (U.S.-Iran conflict) and inflation uncertainty, which can disrupt global banking operations and compress valuation multiples for financial stocks.
C Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a 108.98% gain over the past year. As of the latest close at $132.18, the price is trading at approximately 99% of its 52-week high of $133.57, indicating it is testing the upper boundary of its range and is in a state of extreme momentum, though this also suggests potential for near-term overextension or consolidation. Recent momentum has been exceptionally strong, with the stock surging 21.63% over the past month and 11.98% over the past three months, significantly outpacing the S&P 500's returns of 7.36% and 2.67% over the same periods, respectively; this acceleration from the longer-term trend signals powerful bullish conviction, likely fueled by strong earnings and positive analyst sentiment. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $133.57 and support at the 52-week low of $61.95. A decisive breakout above $133.57 would signal a continuation of the uptrend and open the door to new all-time highs, while a failure here could lead to a pullback toward recent support zones near $110-$115. With a beta of 1.085, the stock exhibits volatility roughly in line with the broader market, but its recent price action demonstrates it can deliver amplified returns during positive market moves, a factor important for risk-adjusted positioning.
Beta
1.08
1.08x market volatility
Max Drawdown
-21.9%
Largest decline past year
52-Week Range
$66-$135
Price range past year
Annual Return
+93.8%
Cumulative gain past year
| Period | C Return | S&P 500 |
|---|---|---|
| 1m | +13.0% | +8.5% |
| 3m | +13.1% | +2.8% |
| 6m | +30.1% | +4.6% |
| 1y | +93.8% | +32.3% |
| ytd | +8.3% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
C Fundamental Analysis
Revenue growth has been mixed but showed a strong sequential improvement in the latest quarter; Q4 2025 revenue was $40.86 billion, representing a slight year-over-year decline of -0.11%, but this follows a stronger Q3 2025 where revenue was $43.84 billion. The revenue segment data highlights Services ($5.94B) and Markets ($4.54B) as significant contributors, with U.S. Personal Banking ($5.29B) also a major driver, indicating a balanced growth profile across institutional and consumer businesses. The trajectory suggests the bank is successfully navigating a complex operating environment to stabilize its top line. Profitability is solid and margins are healthy; the company reported net income of $2.43 billion for Q4 2025, with a net margin of 5.96% and a gross margin of 43.2%. Operating margin for the quarter was 9.33%. While the Q4 net income of $2.43B was lower than the $3.75B in Q3, the full-year profitability picture remains robust, and the operating margin of 11.78% (from valuation data) indicates efficient core operations for a global bank, with room for further expansion as restructuring benefits materialize. The balance sheet shows a leveraged but typical structure for a major bank, with a debt-to-equity ratio of 3.37. Liquidity, as measured by the current ratio, is 0.48, which is standard for banks that fund long-term assets with short-term liabilities. Return on Equity (ROE) is a respectable 6.72%, and Return on Assets (ROA) is 0.61%, reflecting adequate but not stellar capital efficiency. Notably, trailing twelve-month free cash flow is reported as a significant negative $97.04 billion, which is common for banks due to large investing activities (loan origination, security purchases) and not necessarily a sign of distress; the key is the bank's ability to generate stable operating cash flow, which was positive $3.67 billion in Q4 2025.
Quarterly Revenue
$40.9B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.43%
Latest Quarter
Free Cash Flow
$-97.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is C Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. Citigroup trades at a trailing PE of 14.89x and a forward PE of 10.69x. The meaningful discount of the forward multiple implies the market anticipates significant earnings growth, with analysts projecting forward EPS of approximately $18.10, a substantial increase from the trailing diluted EPS of $1.19 from the latest quarter. Compared to industry averages, Citigroup's valuation presents a complex picture. Its trailing PE of 14.89x is below the typical range for high-growth financials but reasonable for a large, diversified bank. The Price-to-Book (PB) ratio of 1.00 indicates the stock is trading precisely at its reported book value, which often represents a floor valuation for banks and suggests the market is not assigning a premium for growth or excess profitability at this time. The Price-to-Sales (PS) ratio of 1.26 is modest, reflecting the bank's high revenue base relative to its market capitalization. Historically, the current trailing PE of 14.89x represents a significant expansion from its recent past; for instance, the PE ratio was 8.21x at the end of Q1 2025 and 11.63x at the end of Q4 2024. This re-rating to a higher multiple band suggests the market is increasingly pricing in the success of the turnaround strategy and improved future earnings power. However, trading near the top of its recent historical valuation range also indicates that much of the positive narrative may already be reflected in the price.
PE
14.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -13x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Citigroup's primary financial risk stems from its leveraged balance sheet, with a debt-to-equity ratio of 3.37, which magnifies the impact of interest rate shifts and credit losses. While quarterly net income has shown volatility—dropping from $4.06B in Q1 2025 to $2.43B in Q4 2025—the bigger concern is revenue stagnation, with a -0.11% YoY decline in the latest quarter. The bank's valuation is heavily dependent on executing its strategic plan to boost efficiency and earnings, as the current forward P/E of 10.69x embeds high growth expectations from a low EPS base of $1.19 (latest quarter). Market & Competitive Risks: The stock faces significant valuation compression risk after its trailing P/E expanded from 8.21x to 14.89x within a year, now trading near the top of its historical range. As a global bank with a beta of 1.085, it is sensitive to macroeconomic shifts, including Federal Reserve policy and geopolitical instability, as highlighted by recent news on U.S.-Iran tensions disrupting markets. Furthermore, the stock's 108.98% annual gain makes it vulnerable to profit-taking and sector rotation out of financials if economic growth concerns resurface. Worst-Case Scenario: The most damaging scenario would involve a combination of a severe economic downturn triggering higher loan losses, a failure to achieve the projected $18.10 EPS, and a resurgence of geopolitical risk compressing bank multiples. This could unravel the turnaround narrative, leading analysts to downgrade ratings. A realistic downside could see the stock re-testing its 52-week low of $61.95, representing a potential loss of approximately -53% from the current price of $132.18. A more probable adverse scenario, aligning with a bear-case analyst target, might involve a pullback to the $90-$100 range (a -24% to -32% decline), based on a reversion to a lower historical P/E multiple on disappointing earnings.
FAQ
The key risks are, in order of severity: 1) Execution Risk: The stock's valuation hinges on delivering EPS of ~$18.10; any stumble could cause a sharp multiple contraction. 2) Macroeconomic Risk: With a beta of 1.085 and high financial leverage (D/E of 3.37), a recession or rate shock could hurt profits and capital ratios. 3) Geopolitical Risk: As a global bank, operations in over 160 countries expose it to instability, as seen in recent U.S.-Iran tension news. 4) Stagnant Growth Risk: Revenue growth was -0.11% YoY last quarter; without top-line expansion, margin improvements may not be enough to drive sustained earnings growth.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $125 and $140, as the company meets consensus EPS estimates near $18.10. The Bull Case (30% probability) targets $145 to $160, driven by flawless execution and P/E expansion. The Bear Case (15% probability) warns of a drop to $90-$110 on earnings misses or a macro downturn. The most likely outcome is the Base Case, predicated on the assumption that Citigroup delivers on its well-telegraphed earnings recovery plan without major setbacks.
Citigroup is fairly valued relative to its immediate prospects but carries an elevated price for its promised future. Its trailing P/E of 14.89x is at the high end of its recent historical range, reflecting the successful turnaround narrative. However, its forward P/E of 10.69x and Price-to-Book ratio of 1.00 suggest the market is not overpaying for expected growth and is valuing it precisely at its accounting net worth. Compared to simply buying the bank's assets (P/B=1.0), it is fairly valued. The valuation implies the market expects near-perfect execution to nearly quintuple EPS from recent quarterly levels.
Citigroup is a good buy for investors who already believe in the multi-year turnaround thesis and are seeking a long-term holding, but it is not an optimal entry for new money at current prices. The stock has surged 109% in a year and trades at 99% of its 52-week high, limiting near-term upside. While the forward P/E of 10.69x is reasonable if the bank hits its $18.10 EPS target, the biggest downside risk is a failure to execute, which could lead to a sharp de-rating. It is a good buy on a meaningful pullback (e.g., toward $115) for patient investors, but a Hold at present levels.
Citigroup is unequivocally suitable for a long-term investment horizon of 3-5 years, not for short-term trading. The turnaround story is a multi-year process, and the stock's high beta (1.085) and recent extreme volatility make it unpredictable in the short term. The modest 2.53% dividend yield supports a total-return, long-term holding strategy. Investors should be prepared to hold through potential volatility to allow the strategic plan to fully unfold and for the projected EPS growth to materialize. A minimum holding period of 18-24 months is suggested to properly assess execution.